Literature DB >> 15937107

Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactor.

Nir Modiano1, Yanping E Lu, Peter Cresswell.   

Abstract

Human guanylate-binding protein-1 (hGBP-1) is a large GTPase, similar in structure to the dynamins. Like many smaller GTPases of the Ras/Rab family, it is farnesylated, suggesting it may dock into membranes and perhaps play a role in intracellular trafficking. To date, however, hGBP-1 has never been associated with a specific intracellular compartment. Here we present evidence that hGBP-1 can associate with the Golgi apparatus. Redistribution from the cytosol to the Golgi was observed by immunofluorescence and subcellular fractionation after aluminum fluoride treatment, suggesting that it occurs when hGBP-1 is in its GTP-bound state. Relocalization was blocked by a farnesyl transferase inhibitor. The C589S mutant of hGBP-1, which cannot be farnesylated, and the previously uncharacterized R48P mutant, which cannot bind GTP, both failed to localize to the Golgi. These two mutants had a dominant-negative effect, preventing endogenous wild-type hGBP-1 from efficiently redistributing after aluminum fluoride treatment. Furthermore, hGBP-1 requires another IFN-gamma-induced factor to be targeted to the Golgi, because constitutively expressed hGBP-1 remained cytosolic in cells treated with aluminum fluoride unless the cells were preincubated with IFN-gamma. Finally, two nonhydrolyzing mutants of hGBP-1, corresponding to active mutants of Ras family proteins, failed to constitutively associate with the Golgi; we propose three possible explanations for this surprising result.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937107      PMCID: PMC1150846          DOI: 10.1073/pnas.0503227102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Different subcellular localizations for the related interferon-induced GTPases, MuGBP-1 and MuGBP-2: implications for different functions?

Authors:  D J Vestal; V Y Gorbacheva; G C Sen
Journal:  J Interferon Cytokine Res       Date:  2000-11       Impact factor: 2.607

2.  Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects.

Authors:  G C Prendergast
Journal:  Curr Opin Cell Biol       Date:  2000-04       Impact factor: 8.382

3.  Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP.

Authors:  G A Taylor; C M Collazo; G S Yap; K Nguyen; T A Gregorio; L S Taylor; B Eagleson; L Secrest; E A Southon; S W Reid; L Tessarollo; M Bray; D W McVicar; K L Komschlies; H A Young; C A Biron; A Sher; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

4.  Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus.

Authors:  K C Chin; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Characterization of herpes simplex virus-containing organelles by subcellular fractionation: role for organelle acidification in assembly of infectious particles.

Authors:  C A Harley; A Dasgupta; D W Wilson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines.

Authors:  E Guenzi; K Töpolt; E Cornali; C Lubeseder-Martellato; A Jörg; K Matzen; C Zietz; E Kremmer; F Nappi; M Schwemmle; C Hohenadl; G Barillari; E Tschachler; P Monini; B Ensoli; M Stürzl
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP1) and identification of the third GTP-binding motif.

Authors:  G J Praefcke; M Geyer; M Schwemmle; H Robert Kalbitzer; C Herrmann
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

8.  Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism.

Authors:  B Prakash; L Renault; G J Praefcke; C Herrmann; A Wittinghofer
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

9.  GTPase mechanism and function: new insights from systematic mutational analysis of the phosphate-binding loop residue Ala30 of Rab5.

Authors:  Z Liang; T Mather; G Li
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

10.  Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon-gamma-inducible guanosine triphosphate-binding protein.

Authors:  J T Stickney; J E Buss
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

View more
  28 in total

1.  Dimerization and its role in GMP formation by human guanylate binding proteins.

Authors:  Nazish Abdullah; Meena Balakumari; Apurba Kumar Sau
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

2.  The GTPase activity of murine guanylate-binding protein 2 (mGBP2) controls the intracellular localization and recruitment to the parasitophorous vacuole of Toxoplasma gondii.

Authors:  Elisabeth Kravets; Daniel Degrandi; Stefanie Weidtkamp-Peters; Britta Ries; Carolin Konermann; Suren Felekyan; Julia M Dargazanli; Gerrit J K Praefcke; Claus A M Seidel; Lutz Schmitt; Sander H J Smits; Klaus Pfeffer
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

Review 3.  Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells.

Authors:  Ryan G Gaudet; Clinton J Bradfield; John D MacMicking
Journal:  Microbiol Spectr       Date:  2016-12

4.  Guanylate-Binding Protein 1 Inhibits Nuclear Delivery of Kaposi's Sarcoma-Associated Herpesvirus Virions by Disrupting Formation of Actin Filament.

Authors:  Zhe Zou; Zhihua Meng; Chao Ma; Deguang Liang; Rui Sun; Ke Lan
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

5.  Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis.

Authors:  Elisabeth Naschberger; Clara Lubeseder-Martellato; Nadine Meyer; Ruth Gessner; Elisabeth Kremmer; Andrè Gessner; Michael Stürzl
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation.

Authors:  José Carlos Santos; Mathias S Dick; Brice Lagrange; Daniel Degrandi; Klaus Pfeffer; Masahiro Yamamoto; Etienne Meunier; Pawel Pelczar; Thomas Henry; Petr Broz
Journal:  EMBO J       Date:  2018-02-19       Impact factor: 11.598

7.  Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles.

Authors:  Weihua Zeng; Akira Miyazato; Guibin Chen; Sachiko Kajigaya; Neal S Young; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2005-08-30       Impact factor: 22.113

8.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

9.  Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner.

Authors:  Nathalie Britzen-Laurent; Michael Bauer; Valeria Berton; Nicole Fischer; Adrian Syguda; Simone Reipschläger; Elisabeth Naschberger; Christian Herrmann; Michael Stürzl
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

10.  Human guanylate binding proteins potentiate the anti-chlamydia effects of interferon-gamma.

Authors:  Illya Tietzel; Christelle El-Haibi; Rey A Carabeo
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.